Renaissance Group »

Adma Biologics shares owned by Renaissance Group

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Renaissance Group from 13F filings

Historical chart of Renaissance Group investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Renaissance Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Renaissance Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.6M 517k 14.66
2025-06-30 $6.3M 344k 18.21

More positions owned by Renaissance Group

Applovin Corp Com Cl A (APP)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Arista Networks Com Shs (ANET)
Emcor (EME)
Meta Platforms Cl A (META)
Apple (AAPL)
Comfort Systems USA (FIX)
Amphenol Corp Cl A (APH)
Netflix (NFLX)
Kla Corp Com New (KLAC)
Applied Materials (AMAT)
Amazon (AMZN)
Cadence Design Systems (CDNS)

View all positions for Renaissance Group

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Geode Capital Management
Nuveen
Westfield Capital Management Company
Dimensional Fund Advisors
American Century Companies
Thrivent Financial for Lutherans
Citadel Advisors
Capital Research Global Investors
Goldman Sachs Group
Franklin Resources

View all funds holding Adma Biologics